Tag: cancer drugs
-
Third of New Cancer Drugs Improve Survival Rates: Ireland’s Pharmacoeconomics Debate
Overview: A Third of New Cancer Drugs Improve Survival Recent discussions at a conference on medicines in Ireland highlighted a striking paradox: while new cancer drugs hold promise, only about a third demonstrably extend overall survival for patients. The head of the National Centre for Pharmacoeconomics warned that many cancer therapies—even those approved—do not translate…
-
New Cancer Drugs: Survival Rates and Value in Ireland
Overview: Balancing Innovation with Value for Money The latest insights from Ireland’s National Centre for Pharmacoeconomics (NCPE) highlight a key tension in modern oncology: while many new cancer medicines promise breakthroughs, only a fraction clearly improves overall survival for patients. At a recent medicines conference, Professor Michael Barry outlined that roughly one third of newly…
-
Third of New Cancer Drugs Improve Survival Rates
Summary: A balance between benefit and cost Recent insights from Ireland’s National Centre for Pharmacoeconomics highlight a cautious reality in cancer care. While many new medicines promise advances in treatment, only about one in three new cancer drugs demonstrate an improvement in overall survival. This finding comes as the centre assesses value for money to…